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Abstract
Background: African swine fever (ASF) is a viral infectious disease of domestic and wild suids of all breeds and ages,
causing a wide range of hemorrhagic syndromes and frequently characterized by high mortality. The disease is endemic
in Sub-Saharan Africa and Sardinia. Since 2007, it has also been present in different countries of Eastern Europe, where
control measures have not been effective so far. The continued spread poses a serious threat to the swine industry
worldwide. In the absence of vaccine, early detection of infected animals is of paramount importance for control of the
outbreak, to prevent the transmission of the virus to healthy animals and subsequent spreading of the disease. Current
laboratory diagnosis is mainly based on virological methods (antigen and genome detection) and serodiagnosis.
Results: In the present work, a Lateral Flow Assay (LFA) for antigen detection has been developed and evaluated. The
test is based on the use of a MAb against VP72 protein of ASFV, the major viral capsid protein and highly immunogenic.
First experiments using VP72 viral and recombinant protein or inactivated culture virus showed promising results with a
sensitivity similar to that of a commercially available Antigen-ELISA. Moreover, these strips were tested with blood from
experimentally infected pigs and field animals and the results compared with those of PCR and Antigen-ELISA. For the
experimentally infected samples, there was an excellent correlation between the LFA and the ELISA, while the PCR always
showed to be more sensitive (38 % positive samples by PCR versus 27 % by LFA). The LFA was demonstrated to be
positive for animals with circulating virus levels exceeding 104 HAU. With the field samples, once again, the PCR detected
more positives than either the Antigen-ELISA or LFA, although here the number of positive samples scored by the LFA
exceeded the values obtained with the Antigen-ELISA, showing 60 % positivity vs 48 % for the ELISA. For the two groups
of sera, the specificity was close to 100 % indicating that hardly any false positive samples were found.
Conclusions: The newly developed LFA allows rapid and reliable detection of ASFV, at field and laboratory level, providing
a new useful tool for control programs and in situations where laboratory support and skilled personnel are limited.
Keywords: African swine fever virus, Lateral flow assay, Diagnosis
Background
African swine fever virus (ASFV) is a large, enveloped,
icosahedral double-stranded DNA virus that belongs to
the Asfaviridae family, genus Asfivirus [1]. ASFV was first
identified in 1921 in Kenya as the cause of lethal
hemorrhagic disease in domestic pigs [2]. In Europe, ASF
was introduced to Portugal in 1957, and from 1960, in
other countries such as Spain or Italy and the Caribbean
islands, but finally eradicated. Currently, the disease is
endemic in the majority of Sub-Saharan countries and
Sardinia (Italy) [3, 4]. Since the introduction of ASFV into
Georgia in 2007 from East Africa, several cases have been
declared in Armenia, Azerbaijan and in the Russian Feder-
ation, where continued uncontrolled spreading poses a
serious threat to the swine industry worldwide [5–8]. The
disease again manifested itself in early 2014, when the first
cases of ASF in wild boar in Lithuania and Poland were
reported in areas bordering on Belarus. Since then, the
ASFV has spread in Estonia, Latvia, Lithuania and Poland,
mostly affecting wild boar and to a lesser extent domestic
pigs [9, 10]. Presently, the disease is threatening other
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regions in Europe and Asia due to the potential persistent
spillover of the virus to adjacent areas.
The natural hosts of ASFV are the domestic and wild
suids, and soft ticks of the genus Ornithodoros. The
infection of warthogs and bushpigs in Africa results in
mild disease, often asymptomatic, with low viraemia
titers, developing into a persistent infection in most
cases [4, 11–13]. These animals act as reservoir hosts of
ASFV in Africa. On the other hand, infection of domestic
pigs, European wild boar, and American wild pigs leads to
more acute diseases with high rates of morbidity and
mortality [14].
At present, no treatment or vaccine is available to
prevent ASF and the control strategy mainly relies on
enforcement of sanitary measures and slaughtering of
infected and exposed animals [15]. Therefore, early and
specific diagnosis of the infection is urgently required
for prevention, control, and eradication of the disease in
affected countries. In the majority of cases, the severe
nature of the epidemic disease affecting the Eastern
European countries leads to mortality with high levels of
viral presence in tissues and blood [16–19]. Therefore,
the ASF diagnosis in the National Reference Laborator-
ies of the affected countries should always include the
detection of the virus, the antigen or the ASFV genome.
The OIE-recommended tests for virus detection include
virus isolation, fluorescent antibody test and both real-
time and conventional PCR assays [20, 21]. However,
these methods are still rather time consuming and re-
quire well-equipped laboratories and personnel, delaying
the disease diagnosis in remote areas [22–25].
In the present report we describe a novel approach for
detection of viral antigen by an immunochromato-
graphic test, based on the use of a monoclonal antibody
against the major viral capsid protein of ASFV, VP72.
The test was first set up using semi-purified viral protein
and inactivated tissue culture virus. Further studies for
validation of the test were carried out using experi-
mental and field serum samples. This novel pen-side
test offers a rapid and simple assay that will allow
early detection of ASFV infection, especially useful
for testing wild suids in the field, and for use in small
laboratories, where laboratory equipment is very
simple or absent.
Methods
Monoclonal antibodies and sera
Monoclonal antibody (mAb) 18BG3, specific for the
VP72 protein, was produced by Ingenasa, following the
previously described protocol by other authors [26].
For this study, two groups of sera were used:
Porcine samples from ASFV experimental studies
Pigs used for experimental studies were obtained from
a local commercial farm. One hundred and fifty three
EDTA-blood samples were collected at regular intervals
until the end of the study, from three independent
experimental infections with virulent ASFV isolates
belonging to P72 genotype II, currently circulating in East
Europe, and IX, which is present in East Africa. The num-
ber and type of experimental samples is summarized in
Table 1. Animal experiments were conducted at the BSL3
animal facilities at INIA in accordance with EC Directive
86/609/EEC, which regulates the accommodation and
care of animals used for experimental and other scientific
purposes. The experiments were conducted as follows:
Experimental infections with ASFV Ken06. Bus isolate
(Kenya 2006): four Landrace x Large White pigs were in-
oculated intramuscularly with 10 HAD50/ml of the ASFV
Ken06-Bus isolate. Two untreated pigs were maintained
in contact, housed in the same box as the inoculated ani-
mals. Inoculated and in-contact animals developed acute
forms of clinical disease and were slaughtered or died as a
result of the infection, between 8 to 17 days post inocula-
tion (dpi)/ days post-exposure (dpe) [27, 28].
Experimental infection with the ASFV Ukr12/Zapo iso-
late (Ukraine 2012): four domestic pigs were inoculated by
the intramuscular route with 10 HAD50/ml of the Ukraine
ASFV Ukr12/Zapo isolate. The inoculated pigs were placed
in contact with two naive pigs being housed in the same
box. All the pigs developed peracute to acute form of the
disease and died, or were ethically slaughtered, between 4
and 10 dpi (for infected pigs) and 11–12 dpe (for in-contact
pigs) [29].
Experimental infections with ASFV LT14/1490 isolate
(Lithuania 2014): ten naive pigs were placed in contact
with eight pigs experimentally inoculated by the intramus-
cular route with 10 HAD50/ml of the Lithuanian LT14/
1490 strain. The Lithuanian ASFV strain induced an acute
disease which resulted in 94,5 % mortality. Seven of the










Acute Virulent Ken06.Bus Kenya (IX) 6 0–14 23 Tignon et al., 2011 [27]
Acute Virulent Ukr12/Zapo Ukraine (II) 6 0–12 19 Gallardo et al., 2013
Acute Virulent LT14/1490 Lithuania (II) 18 0–61 111 Gallardo et al., 2015 [18, 20]
Total samples tested 153
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eight inoculated animals, died or were euthanized due to
the severity of symptoms between 7 and 9 dpi. One inocu-
lated pig showed a delayed course of the disease, resem-
bling the course observed in the in-contact animals, which
died or were slaughtered between 14 and 22 dpe. One in-
contact pig remained asymptomatic throughout the
experiment and was slaughtered at day 61 [30].
Porcine samples from field ASFV-infected areas within
the EUA.
Panel of 58 field EDTA-blood samples collected during
the 2014 and 2015 outbreaks in EU countries (Lithuania,
Poland and Estonia) were used in this study. These samples
were taken from 46 wild boar and 12 domestic pigs during
the surveillance programs and were sent to INIA-CISA’ by
the National Reference Laboratories (NRLs) of Lithuania,
Poland and Estonia for confirmatory diagnosis in accord-
ance with the duties of INIA-CISA as EURL for ASF.
Development and assembly of the lateral flow device
Capture reagents
MAb to VP72 protein (18BG3) was used as the test line
capture reagent. The 18BG3 MAb was diluted to 1 mg/
ml in Tris/HCl 20 mM buffer at pH 7.5 containing 5 %
sucrose and 0.095 % sodium azide as preservative. The
anti-control protein IgG monoclonal antibody was used
as the control line capture reagent. It was diluted to
1 mg/ml in the same buffer used for the test lines. The
control line is essential in order to validate the test.
The test and control capture reagents were dispensed
in two parallel lines on 25 × 300 mm HiFlow Plus nitro-
cellulose membrane (HF120, Millipore) at 1 μl/cm. After
drying for 5 min at 45 °C, the membranes were sealed
and stored at room temperature under dry conditions.
Preparation of latex microparticle conjugates
The detector reagents consisted of 415 nm coloured
carboxyl-modified latex microspheres (Estapor® Micro-
spheres). The MAb against VP72 protein was covalently
conjugated to black latex beads while blue latex particles
were covalently conjugated with the LFA control de-
tector reagent. Previously to protein conjugation, latex
particles were activated with EDC (1-ethyl-3-(3-dimethy-
laminopropyl) carbodiimide hydrochloride) and NHS
(N-Hydroxysuccinimide) and then coupled to the mono-
clonal antibody at a surface concentration of 1 mg/m2.
Finally, conjugated latex particles were diluted in Tris/
HCl 10 mM pH 8.2 and the microsphere solutions were
stored at 4 °C before use.
Preparation of the conjugate pad
To prepare the conjugate solution, the MAb-latex and
control-latex particles previously prepared were diluted at a
concentration of 0.2 % each, in a Tris/HCl 25 mM pH 9.5
buffer containing humidity preservatives and blocking
agents. The mixture was dispensed onto the rayon conju-
gate pad. The pads were dried for 30 min at 45 °C and
stored at room temperature under dry conditions.
Preparation of chromatographic strips
A master card was assembled as follows: nitrocellulose
membrane, conjugated pad, sample pad and absorbent
pad were pasted on a plastic backing with adhesive and
covered with a protector film. The master card was then
cut into strips of 4.2 mm width, which were placed indi-
vidually in a plastic device. A special sample pad to re-
tain the erythrocytes (Cytosep 1662) was used, since the
test was designed to be used with blood samples.
Test procedure
The test has been designed for use with blood samples.
Blood samples must be fresh or refrigerated up to 4 days
at 2–8 °C and collected with an anticoagulant (EDTA,
heparin, etc.). Blood samples without anticoagulant could
contain micro-clots that could block the device and result
in nonspecific reactions. It is also very important to ensure
the devices are stored in dry conditions, to avoid any
negative effect on the result. Finally, several trials in the
lab have demonstrated that the test runs correctly in a
range of temperatures from 15 to 37 °C (data not shown).
Twenty microliters of sample (blood) are applied to the
sample pad followed by 120 μl of running buffer (Tris/
HCl pH 7.5, NaCl, casein, Tween-20 and NaN3 as preser-
vative). The mixture migrates through the conjugate pad
and the nitrocellulose membrane by capillarity. Results are
interpreted 10 minutes after adding the sample. In the
presence of ASFV, the VP72 protein is captured first by
the MAb-coated microparticles, forming a latex-antibody-
antigen immune complex. This immune complex then
reacts with the immobilized MAb on the membrane, mak-
ing the black test line visible along with the blue control
line. In the case of a negative test, only a blue line appears.
The blue control line must appear always; otherwise, the
test has to be considered invalid.
ASF virus detection
ASFV genome detection by PCR
Field and experimental samples were tested for ASFV
genome detection using the OIE real-time PCR [21, 31]
and the Universal Probe Library (UPL) real-time PCR
[32]. The DNA was extracted from each blood sample
using the High Pure PCR Template Preparation Kit
(Roche Diagnostics GmbH, Roche Applied Science,
Mannheim, Germany). For amplification of the ASFV
genomic DNA the PCRs were carried out using un-
diluted and 1/10 diluted extracted DNA for each sample.
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ASFV antigen detection by ELISA
Experimental and blood samples were tested for ASF
antigen detection using a commercially available antigen
detection ELISA, the Double Antibody Sandwich (DAS)
ELISA test manufactured by INGENASA (®INGENASA-
INgezim PPA DAS K2, INGENASA, Madrid, Spain).
The samples were analysed undiluted and at 1/10 dilu-
tion according to the manufacturer’s instructions and
the results obtained were compared to those obtained
using the PCR assays and the new LFA developed.
ASF virus isolation and titration
Virus isolation was assessed in PCR-positive experimen-
tal samples using a hemadsorption assay on PBMC (Per-
ipheral blood mononuclear cells), as described in the
Manual of Diagnostic Tests and Vaccines for Terrestrial
Animals [21]. The plates were examined for hemadsorp-
tion over a period of 6 days. Samples were blind pas-
saged three times. Titres were estimated using a
hemadsorption assay, to monitor the end-point dilution
of ASFV isolates on PBMC by the Reed and Muench
method, and expressed as 50 % hemadsorbing doses per
ml (HAD50/ml) per sample.
Statistical analysis
The concordance between each test was the overall per-
centage agreement between the results of the two assays
calculated using two-by-two contingency tables. Kappa
Coefficient (k) statistics were used to evaluate the signifi-
cance of the level of concordance between results
beyond that expected by chance, with k values of 0.81–
1.00 representing almost perfect agreement, values of
0.61–0.80 substantial agreement, values of 0.41–0.60
good agreement, values of 0.21–0.40 moderate agree-
ment, values of 0.01–0.20 slight agreement, and values
of 0.00 no agreement (48). From the overall analysis of
the results the final sensitivity and specificity of the new
assay were calculated using the results of the UPL-PCR
as a reference test for virus detection. Values measured
included the number of true positives (TP), the number
of true negatives (TN), the number of false positives
(FP) and the number of false negatives (FN). Sensitivity
was calculated as 100 × TP/(TP + FN), specificity was
calculated as 100 × TN/(TN + FP).
Results
Development of the immunochromatographic assay
A monoclonal antibody, 18BG3, against the VP72 protein
of ASFV, was used as the capture reagent on the test line in
the LFA for ASFV detection. A specific monoclonal anti-
body for the control protein was used as the control line.
Since it is known that over 90 % of the virus is associ-
ated with red blood cells [33], our purpose was to adapt
the test to be used not only with serum samples, but
more importantly with blood samples. Therefore, a
special sample pad was used in the design of the test, in
order to retain the erythrocytes, allowing the free virus
to move along the strip. Besides, different running
buffers containing detergent were tested in order to
release as much virus as possible from the erythrocytes.
Different colored beads were analyzed for antibody
conjugation, taking into consideration that in case of
hemolized blood samples, hemoglobin would move
along the strip, staining it and thus making the
visualization of the test line more difficult. For this rea-
son, black latex beads were chosen to develop the test.
Moreover, different antibody concentrations for conjuga-
tion to the latex beads were also studied to determine
optimal conditions. Finally, the test protocol was estab-
lished as follows: after addition of the sample to the
round window of the device, the running buffer is added
and after ten minutes, the results must be interpreted.
Appearance of a black test line and the blue control line
indicates a positive result, while appearance of the con-
trol line alone indicates a negative sample (Fig. 1).
Performance of the LFA for ASFV detection
In order to test the performance of the newly developed
test, first experiments were carried out using semi-
purified VP72 viral protein and inactivated tissue culture
virus, BA71 strain. A spike-in test was assessed in the
laboratory by adding the viral semi-purified protein to
blood from a healthy donor pig used as the matrix. Serial
dilutions of the viral protein in blood were analyzed by
LFA. The analytical sensitivity of the assay was down to
3 ng/test, comparable to that of a commercially available
double antibody sandwich ELISA (INgezim® PPA DAS)
with 1.9 ng/test (Fig. 2). When the test was performed
using the tissue culture virus, the detection limit was
down to 104 pfu/ml (data not shown).
Evaluation of the LFA for ASFV detection
Out of the 153 blood samples collected at different times
post infection from the 30 experimentally infected pigs,
the number of positives using the UPL rt-PCR was 60
(39.21 %), 57 (37.25 %) using the OIE rt-PCR and 41
(26.79 %) using the LFA. Thirteen out of the 19 samples
(68.42 %) which gave a false negative result with the LFA
were correlated to blood samples with rt-PCR Cycle
Threshold (CT) values above 30, mainly collected at
initial stages of the infection or from in-contact animals
exposed to the virulent Lithuania 2014 ASFV isolate
(LT14/1490), which remained asymptomatic throughout
the experimental infection (Table 2). When comparing
with the virus isolation, the LFA was unable to detect
the presence of ASFV antigen in blood samples with
viral loads below 104 HAU. Good correlation was
observed between the LFA and the antigen INgezim®
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PPA DAS ELISA with just 2 of the 41 ELISA positive
samples testing negative in the LFA. Among the negative
samples, two were tested as false positives by using the
LFA whereas only one produced a false positive when
tested with the antigen-ELISA.
To evaluate the ability of the new LFA to diagnose
ASF during the current epidemic outbreaks in the EU
countries, 58 samples collected in 2014 and 2015, from
domestic pigs (12) and wild boar (46) from affected EU
countries were included in the study. The samples were
tested in parallel using the two real time PCRs, the
antigen-ELISA and the LFA. As with the results obtained
using the experimental blood samples, the number of
positive samples detected by the UPL-rt-PCR was 52
(89.65 %), whereas the number decreased to 51
(87.93 %) with the OIE rt-PCR, 35 (60.34 %) with the
LFA and 28 (48.27 %) with the INgezim® PPA DAS
ELISA assay (Table 3). Contrary to what was observed in
the analysis of the experimental samples, only 7 out of
the 17 (41 %) samples which resulted false negatives
using the LFA displayed Ct values above 30 (Table 4).
From the results obtained in both experimental and
field samples collected from animals with known infec-
tious status and selecting the UPL-PCR as the reference
method, the sensitivity and specificity of the LFA were
calculated. Of the 112 ASF positive samples, there were
36 false negatives from the LFA, resulting in a sensitivity
value of 67.86 %. The number of false positive samples
was 2 out of 99 giving a specificity of 97.98 %. When
comparing the LFA results with those obtained using the
INgezim® PPA DAS ELISA assay, the Kappa values of
0.92 [CI 95 % = 0.86–0,98] showed almost perfect agree-
ment between the two assays.
Discussion
Early diagnosis of African swine fever is essential in
order to establish effective surveillance programmes and
control measures to prevent the spread of ASF. Rapid,
sensitive and specific assays are required by diagnostic
laboratories. A positive diagnosis involves the detection
and identification of ASFV-antigens, antibodies or DNA
in a given sample. The development of new easy-to-
handle diagnostic tools designed for non-specialized
front-line laboratories with limited equipment and
allowing deployment at field level, would be very helpful
in improving ASF control programmes. This applies
Fig. 1 Picture of the lateral flow device for ASFV detection. The left
device shows a negative result using a blood sample from a healthy
donor pig; where only the blue control line is detected. The right
test shows a positive result by spiking the semi-purified VP72 protein
in blood; in this scenario, the two lines, control line (blue) and test























Concentration VP72 in blood (µg/mL)
Fig. 2 Comparison of the performance of the LFA and the commercial
DAS-ELISA. Serial dilutions of semi-purified VP72 protein in blood were
tested by LFA and Double antibody sandwich ELISA (DAS-ELISA) and
results were compared. Both assays are based on MAbs specific for
VP72 protein. The detection limit of both tests was very similar (3 ng
viral protein/test by LFA vs 1,9 ng viral protein/test in ELISA)
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particularly to positive results, allowing for control mea-
sures, such as restriction of animal movement, to be
adopted immediately, until confirmation from official
reference laboratories is received. In case of virulent
strains, animals usually develop high levels of viremia,
dying soon after infection. Virus, antigen or genome de-
tection is very useful to diagnose these hyperacute/acute
forms of the disease. In case of ASFV infection with
moderate or low virulent strains, these usually induce
high or medium viremia levels at the beginning of the
infection, and high antibody titers from the second week
post infection. In these cases, both virus and antibody
detection must be used to obtaint a reliable diagnosis.
In the present study, a lateral flow assay for antigen
detection was developed and tested with blood samples
from pigs inoculated experimentally with ASFV and
from field infected animals. The assay was based on a
monoclonal antibody to the VP72 protein, which is the
major capsid protein of ASFV [34, 35] and therefore an
appropriate target antigen for virus detection. The data
obtained by the LFA were compared with those obtained
by both rt-PCR (UPL rt-PCR and OIE rt-PCR) and by
INgezim PPA DAS. It has been recently described that
the UPL-rt-PCR is the most sensitive and trustworthy
method for detecting ASF, followed by the OIE-rt-PCR
[20]. In that study the INgezim PPA DAS was included
Table 2 Description of the false negative (FN) samples using the LFA by the analysis of experimental samples collected from
animals infected with ASFV genotype II and IX viruses










LT14/1490 L10 13 30.88 30.39 3,16 × 103 FN*
LT14/1490 L10 17 17.61 16.49 6,81 × 105 POS
LT14/1490 L11 13 26.43 27.41 3,16 × 102 FN
LT14/1490 L12 13 36.67 37.21 NEGATIVE FN
LT14/1490 L13 3 32.73 32.47 NEGATIVE FN
LT14/1490 L14 17 33.04 34.79 NEGATIVE FN
LT14/1490 L15 13 25.93 24.71 6,81 × 104 FN
LT14/1490 L15 17 18.27 16.73 6,81E × 106 FN
LT14/1490 L16 13 32.41 32.62 NEGATIVE FN
LT14/1490 L17 3 37.46 37.45 NEGATIVE FN
LT14/1490 L17 7 23.14 23.07 3,16 × 105 POS
LT14/1490 L18 17 36.95 FN NEGATIVE FN
LT14/1490 L18 34 38.51 FN NEGATIVE FN
LT14/1490 L18 38 38.46 FN NEGATIVE FN
LT14/1490 L2 14 34.54 33.95 3,16E + 01 FN
LT14/1490 L3 3 32 33.04 NEGATIVE FN
LT14/1490 L4 10 31.67 31.85 3,16E + 03 FN
LT14/1490 L6 14 27.2 26.91 3,16E + 08 FN
Ken06.Bus CC6 D10 35.34 39.63 NEGATIVE FN
*false negative
Table 3 Comparison between the two PCR tests, the antigen-ELISA and the LFA used to detect ASFV in field-collected blood
samples from wild boar and domestic pigs during the epidemic outbreaks in EU countries
Country Host UPL real-time PCR OIE real time PCR LFA Ag-ELISA INGENASA
N° positives/total % N° positives/total % N° positives/total % N° positives/total %
Estonia Wild boar 1/1 100 1/1 100 0/1 0 0/1 0
Latvia Wild boar 1/1 100 0/1 0 0/1 0 0/1 0
Lithuania Wild boar 20/26 76.92 20/26 76.92 9/26 34.61 8/26 34,61
Domestic pig 11/11 100 11/11 100 10/11 90.9 6/11 90,9
Poland Wild boar 18/18 100 18/18 100 15/18 83.3 13/18 83,3
Domestic pig 1/1 100 1/1 100 1/1 100 1/1 100
Total 52/58 89.65 51/58 87.93 35/58 60.34 28/58 48.27
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for comparison purposes, showing a good-to-moderate
agreement with the UPL-rt-PCR (k = 0.67 [95 % CI, 0.58
to 0.76]). The data analyzed in the present work showed
that the sensitivity of the LFA was lower than that
obtained by either rt-PCR, as was expected, detecting 68
and 72 % of the positive samples from experimentally
infected animals, in comparison with UPL-rt-PCR and
OIE-rt-PCR, respectively. Besides, more than 50 % of the
false negative results by LFA corresponded to samples
with CT values higher than 30, obtained from second
week of infection and onwards, and therefore with low
viral loads. Nevertheless, when compared to the results
of the antigen-ELISA, only two false negative samples
were detected by LFA. It is important to take into
account that these two techniques are detecting viral
antigen, while the rt-PCRs detect viral genome, and
therefore being more sensitive. In any case, the specifi-
city of the newly developed test was very close to 100 %,
indicating a low percentage of false positive results,
which is crucial in order to avoid unnecessary states of
alarm and consequent expenses.
In a similar way, when the field samples were analyzed
by the LFA, 67 % of positivity was found in comparison
with the reference technique, UPL-rt-PCR. However, in
this case, the majority of the false negative results did
not show Ct values above 30. This discrepancy could be
due to the quality of the sample, since these field sam-
ples came mostly from carcasses of animals found dead
or hunted. This aspect is critical in the analysis of the
samples by LFA, affecting the result even if the viral
loads are high enough to be detected by this method.
Although PCR is the technique most frequently used
for viral detection, it is a laborious technique, which re-
quires good training to avoid contamination and there-
fore false positive results. Besides, samples need to be
transported quickly to the corresponding laboratory in
order to obtain a result. Although LFA is less sensitive
than rt-PCR tests, this novel pen-side test offers some
advantages and benefits, especially in field scenarios: it is
a rapid, economic and simple-to-use diagnostic tool,
since it does not require any kind of instrumentation
and the result is interpreted at a glance and with very
high specificity. Furthermore, the test has been designed
to be used with blood, thus making sample processing
easy and feasible. All these features make these devices
very suitable for field application or basic laboratories,
especially in countries where laboratory infrastructure is
deficient or even absent. Further validation is currently
ongoing in different countries in Europe, Asia and
Africa. Field validation is particularly crucial before these
tests can be used as front-line diagnostic assays. This
should include samples not only from domestic pigs, but
also wild boar.
Conclusion
In conclusion, the newly developed LFA allows the
detection of ASFV with viral loads from 104 HAU, corre-
sponding to days 4–7 depending on the virulence of the
viral strain and depending on the condition of the sample.
This is a very valuable tool accompanying the antibody
detection tests (including pen-side tests) in any scenario.
It will assist especially local veterinary services, where in
many cases first evidence of the disease is based only on
clinical symptoms.
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Table 4 Description of the false negative (FN) samples using










ESTONIA WILD BOAR 21,46 23,91 FN
LATVIA WILD BOAR 35.99 FN FN
LITHUANIA DOMESTIC PIG 21.29 20.62 FN
LITHUANIA WILD BOAR 24.29 24.5 FN
LITHUANIA WILD BOAR 34.42 38.32 FN
LITHUANIA WILD BOAR 26.3 27.15 POS
LITHUANIA WILD BOAR 25.44 25.91 FN
LITHUANIA WILD BOAR 26.48 26.04 FN
LITHUANIA WILD BOAR 32.97 31.02 FN
LITHUANIA WILD BOAR 21.36 19.01 FN
LITHUANIA WILD BOAR 34.9 35.28 FN
LITHUANIA WILD BOAR 32.81 32.11 FN
LITHUANIA WILD BOAR 34.73 39.95 FN
LITHUANIA WILD BOAR 34.51 34.36 FN
POLAND WILD BOAR 25.44 25.03 POS
POLAND WILD BOAR 24.27 24.59 FN
POLAND WILD BOAR 27.03 27.94 FN
In grey are labelled false negative samples with Ct > 30 by using the UPL-real
time PCR
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